FOXA2 and small cell lung carcinoma: To further interrogate the association of FOXA2 with the clinical outcome of SCLC patients, we prepared a tissue microarray (TMA) containing tumors from 26 cases of limited stage SCLC treated by surgical resection followed by adjuvant chemotherapy (age:55-79, Male 58%, Supplementary Data 3).